- Home
- LGVN vs ABVC Comparison
LGVN vs ABVC Comparison
Compare LGVN & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- ABVC
- Stock Information
- Founded
- LGVN 2014
- ABVC 2015
- Country
- LGVN United States
- ABVC United States
- Employees
- LGVN N/A
- ABVC N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- LGVN Health Care
- ABVC Health Care
- Exchange
- LGVN Nasdaq
- ABVC Nasdaq
- Market Cap
- LGVN 23.4M
- ABVC 22.1M
- IPO Year
- LGVN 2021
- ABVC N/A
- Fundamental
- Price
- LGVN $1.30
- ABVC $2.19
- Analyst Decision
- LGVN Strong Buy
- ABVC
- Analyst Count
- LGVN 3
- ABVC 0
- Target Price
- LGVN $8.67
- ABVC N/A
- AVG Volume (30 Days)
- LGVN 138.8K
- ABVC 312.1K
- Earning Date
- LGVN 08-13-2025
- ABVC 08-13-2025
- Dividend Yield
- LGVN N/A
- ABVC N/A
- EPS Growth
- LGVN N/A
- ABVC N/A
- EPS
- LGVN N/A
- ABVC N/A
- Revenue
- LGVN $2,225,000.00
- ABVC $508,383.00
- Revenue This Year
- LGVN N/A
- ABVC $735.18
- Revenue Next Year
- LGVN $51.48
- ABVC N/A
- P/E Ratio
- LGVN N/A
- ABVC N/A
- Revenue Growth
- LGVN 127.50
- ABVC 1904.43
- 52 Week Low
- LGVN $1.14
- ABVC $0.40
- 52 Week High
- LGVN $6.40
- ABVC $2.29
- Technical
- Relative Strength Index (RSI)
- LGVN 50.13
- ABVC 70.75
- Support Level
- LGVN $1.15
- ABVC $1.84
- Resistance Level
- LGVN $1.32
- ABVC $2.29
- Average True Range (ATR)
- LGVN 0.09
- ABVC 0.16
- MACD
- LGVN 0.01
- ABVC 0.03
- Stochastic Oscillator
- LGVN 45.31
- ABVC 87.65
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.